SCHEDULE 2 REGULATION 21 4-methylhexan-2-amine (methylhexaneamine); benzfetamine; cathine**; cathinone and its analogues, e.g. mephedrone, methedrone, and α- pyrrolidinovalerophenone; dimethylamphetamine; ephedrine***; epinephrine**** (adrenaline); etamivan; etilamfetamine; etilefrine; famprofazone; fenbutrazate; fencamfamin; heptaminol; hydroxyamfetamine (parahydroxyamphetamine); isometheptene; levmetamfetamine; meclofenoxate; methylenedioxymethamphetamine; methylephedrine***; methylphenidate; nikethamide; norfenefrine; octopamine; oxilofrine (methylsynephrine); pemoline; pentetrazol; phenethylamine and its derivatives; phenmetrazine; phenpromethamine; propylhexedrine; pseudoephedrine*****; selegiline; sibutramine; strychnine; tenamfetamine (methylenedioxyamphetamine); tuaminoheptane. and other substances with a similar chemical structure or similar biological effect(s). Except: • Clonidine • Imidazole derivatives for topical/ophthalmic use and those stimulants included in the 2017 Monitoring Program*. * Bupropion, caffeine, nicotine, phenylephrine, phenylpropanolamine, pipradrol, and synephrine: These substances are included in the 2017 Monitoring Program, and are not considered Prohibited Substances. Last update: 3 January, 2017 484
World Rugby Handbook
To see the actual publication please follow the link above